The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver: A national survey

Barry Fortner, Kurt Tauer, Ling Zhu, Lea Ma, Lee Schwartzberg

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Cancer patients are required to make numerous visits to the clinic for cancer treatment and supportive care, including visits for the management of chemotherapy-induced anemia and neutropenia. The aim of this study was to assess the effect of medical visits, specifically visits for the management of chemotherapy-induced anemia and neutropenia, on cancer patients and their caregivers. A semistructured interview was administered by a study nurse to patients from outpatient oncology clinics across the continental US to obtain retrospective data pertaining to the impact of medical visits on patients and caregivers. Data from 15,785 adult cancer patients receiving care at 649 clinics showed that medical visits affect significant patient and caregiver time. Patients reported an average clinic visit for erythropoietin treatment involved 2.2 ± 3.10 (SD) hours for themselves and 1.3 ± 2.51 hours for their caregivers. Patients reported an average clinic visit for neutropenia management involved 2 ± 2.59 hours for themselves and 1.15 ± 2.33 hours for their caregivers. The data are important to developing models that explain and predict the implications of medical visits in overall patient care and quality of life. Moreover, future studies should explore in greater detail specific factors that may dictate patient burden and compare and contrast specific chemotherapy and supportive care regimens in terms of patient and caregiver burden.

Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalCommunity Oncology
Volume1
Issue number4
DOIs
StatePublished - Jan 1 2004

Fingerprint

Neutropenia
Caregivers
Anemia
Drug Therapy
Ambulatory Care
Neoplasms
Patient Care
Surveys and Questionnaires
Erythropoietin
Ambulatory Care Facilities
Nurses
Quality of Life
Interviews
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver : A national survey. / Fortner, Barry; Tauer, Kurt; Zhu, Ling; Ma, Lea; Schwartzberg, Lee.

In: Community Oncology, Vol. 1, No. 4, 01.01.2004, p. 211-217.

Research output: Contribution to journalReview article

@article{f3b2344d45764c1283c66dc4590fe1f9,
title = "The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver: A national survey",
abstract = "Cancer patients are required to make numerous visits to the clinic for cancer treatment and supportive care, including visits for the management of chemotherapy-induced anemia and neutropenia. The aim of this study was to assess the effect of medical visits, specifically visits for the management of chemotherapy-induced anemia and neutropenia, on cancer patients and their caregivers. A semistructured interview was administered by a study nurse to patients from outpatient oncology clinics across the continental US to obtain retrospective data pertaining to the impact of medical visits on patients and caregivers. Data from 15,785 adult cancer patients receiving care at 649 clinics showed that medical visits affect significant patient and caregiver time. Patients reported an average clinic visit for erythropoietin treatment involved 2.2 ± 3.10 (SD) hours for themselves and 1.3 ± 2.51 hours for their caregivers. Patients reported an average clinic visit for neutropenia management involved 2 ± 2.59 hours for themselves and 1.15 ± 2.33 hours for their caregivers. The data are important to developing models that explain and predict the implications of medical visits in overall patient care and quality of life. Moreover, future studies should explore in greater detail specific factors that may dictate patient burden and compare and contrast specific chemotherapy and supportive care regimens in terms of patient and caregiver burden.",
author = "Barry Fortner and Kurt Tauer and Ling Zhu and Lea Ma and Lee Schwartzberg",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S1548-5315(11)70825-7",
language = "English (US)",
volume = "1",
pages = "211--217",
journal = "Community Oncology",
issn = "1548-5315",
publisher = "BioLink Communications",
number = "4",

}

TY - JOUR

T1 - The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver

T2 - A national survey

AU - Fortner, Barry

AU - Tauer, Kurt

AU - Zhu, Ling

AU - Ma, Lea

AU - Schwartzberg, Lee

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Cancer patients are required to make numerous visits to the clinic for cancer treatment and supportive care, including visits for the management of chemotherapy-induced anemia and neutropenia. The aim of this study was to assess the effect of medical visits, specifically visits for the management of chemotherapy-induced anemia and neutropenia, on cancer patients and their caregivers. A semistructured interview was administered by a study nurse to patients from outpatient oncology clinics across the continental US to obtain retrospective data pertaining to the impact of medical visits on patients and caregivers. Data from 15,785 adult cancer patients receiving care at 649 clinics showed that medical visits affect significant patient and caregiver time. Patients reported an average clinic visit for erythropoietin treatment involved 2.2 ± 3.10 (SD) hours for themselves and 1.3 ± 2.51 hours for their caregivers. Patients reported an average clinic visit for neutropenia management involved 2 ± 2.59 hours for themselves and 1.15 ± 2.33 hours for their caregivers. The data are important to developing models that explain and predict the implications of medical visits in overall patient care and quality of life. Moreover, future studies should explore in greater detail specific factors that may dictate patient burden and compare and contrast specific chemotherapy and supportive care regimens in terms of patient and caregiver burden.

AB - Cancer patients are required to make numerous visits to the clinic for cancer treatment and supportive care, including visits for the management of chemotherapy-induced anemia and neutropenia. The aim of this study was to assess the effect of medical visits, specifically visits for the management of chemotherapy-induced anemia and neutropenia, on cancer patients and their caregivers. A semistructured interview was administered by a study nurse to patients from outpatient oncology clinics across the continental US to obtain retrospective data pertaining to the impact of medical visits on patients and caregivers. Data from 15,785 adult cancer patients receiving care at 649 clinics showed that medical visits affect significant patient and caregiver time. Patients reported an average clinic visit for erythropoietin treatment involved 2.2 ± 3.10 (SD) hours for themselves and 1.3 ± 2.51 hours for their caregivers. Patients reported an average clinic visit for neutropenia management involved 2 ± 2.59 hours for themselves and 1.15 ± 2.33 hours for their caregivers. The data are important to developing models that explain and predict the implications of medical visits in overall patient care and quality of life. Moreover, future studies should explore in greater detail specific factors that may dictate patient burden and compare and contrast specific chemotherapy and supportive care regimens in terms of patient and caregiver burden.

UR - http://www.scopus.com/inward/record.url?scp=13844298694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844298694&partnerID=8YFLogxK

U2 - 10.1016/S1548-5315(11)70825-7

DO - 10.1016/S1548-5315(11)70825-7

M3 - Review article

AN - SCOPUS:13844298694

VL - 1

SP - 211

EP - 217

JO - Community Oncology

JF - Community Oncology

SN - 1548-5315

IS - 4

ER -